IE862707L - Dichloroaniline derivatives - Google Patents

Dichloroaniline derivatives

Info

Publication number
IE862707L
IE862707L IE862707A IE270786A IE862707L IE 862707 L IE862707 L IE 862707L IE 862707 A IE862707 A IE 862707A IE 270786 A IE270786 A IE 270786A IE 862707 L IE862707 L IE 862707L
Authority
IE
Ireland
Prior art keywords
group
hydrogen atom
alkoxy
hydroxy
alkyl group
Prior art date
Application number
IE862707A
Other versions
IE59466B1 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IE862707L publication Critical patent/IE862707L/en
Publication of IE59466B1 publication Critical patent/IE59466B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • C07C211/46—Aniline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compounds of the formula (I> <IMAGE> wherein X represents a bond, C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene and Y represents a bond, C1-4 alkylene, C2-4 alkenylene or C2-4 alkynylene, the sum total of carbon atoms in X and Y being not more than 8; Ar represents a phenyl group substituted by one or more substituents selected from nitro, -(CH2)qR [where R is C1-3 alkoxy, -NR<3>R<4> (where R<3> and R<4> each represent a hydrogen atom, or a C1-4 alkyl group, or-NR<3>R<4> forms a saturated heterocyclic amino group which has 5-7 ring members), -NR<5>COR<6> (where R<5> represents a hydrogen atom or a C1-4alkyl group, and R<6> represents a hydrogen atom or a C1-4alkyl, C1-4alkoxy or-NR<3>R<4> group), and q is 1 to 3], -(CH2)rR<7> [where R<7> represents -NR<5>SO2R<8> (where R<8> represents a C1-4 alkyl, phenyl or -NR<3>R<4> group),- NR<5>COCH2N(R<5>)2 (where each of the groups R<5> represents a hydrogen atom or a C1-4 alkyl group), -COR<9 > (where R<9> represents hydroxy, C1-4 alkoxy or a NR<3>R<4>), -SR<10> (where R<10> is a hydrogen atom, or a C1-4 alkyl group optionally substituted by hydroxy, C1-4 alkoxy or NR<3>R<4>), -SOR<10>, -SO2R10, -CN, or -NR11R<12> (where R<11> and R<12> represent a hydrogen atom or a C1-4 alkyl group, at least one of which is C2-4 alkyl substituted by a hydroxy, C1-4 alkoxy or NR<3>R<4> group), and r is 0 to 3], -O(CH2)qCOR<9>, or -O(CH2)tR<13> [where R<13> represents hydroxy, NR<3>R<4>, NR<11>R<12> or a C1-4alkoxy group optionally substituted by hydroxy, C1-4 alkoxy or NR<3>R<4>,and t is 2 or 3]. R<1> and R<2> each represents a hydrogen atom or a C1-3 alkyl group, the sum total of carbon atoms in R<1> and R<2> being not more than 4; and physiologically acceptable salts and solvates (e.g. hydrates) thereof, have a stimulant action at a beta 2-adreno-receptors and may be used in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis. [GB2182658A]
IE270786A 1985-10-15 1986-10-14 Dichloroaniline derivatives IE59466B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525321A GB8525321D0 (en) 1985-10-15 1985-10-15 Chemical compounds

Publications (2)

Publication Number Publication Date
IE862707L true IE862707L (en) 1987-04-15
IE59466B1 IE59466B1 (en) 1994-02-23

Family

ID=10586651

Family Applications (1)

Application Number Title Priority Date Filing Date
IE270786A IE59466B1 (en) 1985-10-15 1986-10-14 Dichloroaniline derivatives

Country Status (21)

Country Link
JP (1) JPS62149651A (en)
KR (1) KR870003970A (en)
AT (1) AT395972B (en)
AU (1) AU591188B2 (en)
BE (1) BE905601A (en)
CA (1) CA1296335C (en)
CH (1) CH669787A5 (en)
DE (1) DE3634974A1 (en)
DK (1) DK491786A (en)
ES (1) ES2002036A6 (en)
FI (1) FI89164C (en)
FR (1) FR2591590B1 (en)
GB (2) GB8525321D0 (en)
IE (1) IE59466B1 (en)
IL (2) IL78432A (en)
IT (1) IT1205360B (en)
NL (1) NL8602575A (en)
NO (1) NO164895C (en)
PT (1) PT83531B (en)
SE (1) SE467541B (en)
ZA (1) ZA867772B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173685A (en) * 1984-04-17 1985-10-18 Glaxo Group Ltd Safety and pouring stopper
US5149698A (en) * 1987-08-11 1992-09-22 Glaxo Group Limited Chloroaniline derivatives
GB8718939D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
GB8718938D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
DE3880628T2 (en) * 1987-11-13 1993-08-05 Glaxo Group Ltd PHENETHANOLAMINE DERIVATIVES.
ZA889405B (en) * 1987-12-18 1989-12-27 Glaxo Group Ltd Ethanolamine derivatives
EP0322164B1 (en) * 1987-12-18 1993-09-22 Glaxo Group Limited Ethanolamine derivatives
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (en) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Process for the preparation of new amino-dihalogen-phenyl-ethylamines
DE2351281C3 (en) * 1973-10-12 1981-07-30 Dr. Karl Thomae Gmbh, 7950 Biberach Aminophenylethanolamine derivatives, their production and use
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
DK173685A (en) * 1984-04-17 1985-10-18 Glaxo Group Ltd Safety and pouring stopper
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds

Also Published As

Publication number Publication date
AU6395986A (en) 1987-04-16
PT83531A (en) 1986-11-01
SE8604349D0 (en) 1986-10-14
GB8624630D0 (en) 1986-11-19
NO164895B (en) 1990-08-20
FI864137A0 (en) 1986-10-14
NO864101L (en) 1987-04-21
SE8604349L (en) 1987-04-16
DK491786A (en) 1987-04-16
NL8602575A (en) 1987-05-04
JPS62149651A (en) 1987-07-03
GB2182658A (en) 1987-05-20
FR2591590B1 (en) 1990-05-11
FI864137A (en) 1987-04-16
IE59466B1 (en) 1994-02-23
ATA273486A (en) 1992-09-15
IL80294A (en) 1990-11-29
GB8525321D0 (en) 1985-11-20
ES2002036A6 (en) 1988-07-01
IT8648547A0 (en) 1986-10-14
CA1296335C (en) 1992-02-25
BE905601A (en) 1987-04-15
IL78432A (en) 1990-09-17
FI89164C (en) 1993-08-25
KR870003970A (en) 1987-05-06
FI89164B (en) 1993-05-14
FR2591590A1 (en) 1987-06-19
AU591188B2 (en) 1989-11-30
NO864101D0 (en) 1986-10-14
DE3634974A1 (en) 1987-05-27
SE467541B (en) 1992-08-03
IT1205360B (en) 1989-03-15
CH669787A5 (en) 1989-04-14
AT395972B (en) 1993-04-26
ZA867772B (en) 1988-07-27
DK491786D0 (en) 1986-10-14
PT83531B (en) 1989-05-31
GB2182658B (en) 1990-01-31
NO164895C (en) 1990-11-28

Similar Documents

Publication Publication Date Title
AU584929B2 (en) Dichloroaniline derivatives
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
NO903438L (en) PROCEDURE FOR THE PREPARATION OF TIAZOLD DERIVATIVES.
NO905572D0 (en) PROCEDURE FOR THE PREPARATION OF PEPTID RELATIONS.
ES2173074T3 (en) DERIVATIVES OF XANTINA, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL USE.
PT81819B (en) PROCESS FOR THE PREPARATION OF AMINOFENOL DERIVATIVES
ES8400393A1 (en) Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions.
IE862707L (en) Dichloroaniline derivatives
DE68926981D1 (en) Cephem compounds and processes for their preparation
AU635445B2 (en) New compounds
CA2064108A1 (en) Thiazolidinone and Oxazolidinone Derivatives, Their Preparation and Their Use as Vasodilators
ES8404311A1 (en) Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application.
DK160486C (en) N - (4-AMINO-2,2-DIPHENYL-BUTYL) - OR N- (3-AMINO-2,2-DIPHENYL-PROPYL)
ATE146476T1 (en) CEPHALOSPORIN COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
ES8105319A1 (en) Pyrazolo[1,5-c]quinazoline derivatives and analgesic compositions containing them
DE69011748D1 (en) Biphenyl derivatives, processes for their preparation and their intermediates.
NZ225771A (en) Heterocyclically-substituted chloroaniline derivatives and pharmaceutical compositions: processes for preparation
IE820160L (en) Heterocyclic benzamide derivatives
ES2040223T3 (en) DERIVATIVES OF THE TIADIAZOLILACETAMIDA, PROCEDURE FOR ITS MANUFACTURE AND ITS USE.
ATE129246T1 (en) PYRAZOLO(1,5-A)PYRIDINES, THEIR PREPARATION AND USE.
MY103817A (en) Chloroaniline derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed